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The importance of individual target genes for miRNA activity has been difficult to establish. In this issue of
Immunity, Lu et al. (2015) disrupt the miR-155 binding site in the SOCS1 30 UTR in the mouse germline and
show that this axis is important for T and NK cell function.For more than a decade now, the study of
microRNAs (miRNAs) within the immune
system has revealed exciting roles for
these small non-coding RNAs in modu-
lating immune responses. Several miR-
NAs are clearly expressed by a wide
range of immune cells, including cells
that comprise both the innate and adap-
tive immune systems, and in some cases,
expression is dependent upon cellular
activation or lineage skewing (O’Connell
et al., 2012). Among the immunologically
relevant miRNAs is miR-155, which was
originally identified as an oncogene is
chicken lymphocytes (Tam et al., 1997)
and subsequently was shown to be
induced in activated immune cells, mak-
ing it an inflammatory response gene
(O’Connell et al., 2007). Further, through
the use of gain- and loss-of-function
approaches, it has become clear that
miR-155, like a handful of other miRNAs,
plays indispensable roles in a variety of
cell types during responses to infection,
during immunization, in the context of
autoimmune reactions, and during tumor
immunity (Vigorito et al., 2013).
As a field, we havemade great strides in
our understanding of miRNA biogenesis,
their expression patterns in distinct cell
types, and the functional importance of
miRNAs in the immune system (O’Connell
et al., 2012). However, our understanding
of the molecular mechanisms by which
miRNAs mediate their functional effects
remains incomplete, especially in terms
of deciphering which direct miRNA tar-
gets are truly responsible for downstream
functional outcomes. miRNAs appear to
function by repressing dosage-sensitive
target genes, which occurs as miRNAs
recognize cognate binding sites in the 30
UTRs of their target mRNAs. This process
also involves recruitment of the RISCcomplex, which mediates target gene
repression. Based upon bioinformatic
predictions, assaying de-repression of
predicted targets in miRNA knockout
cells, conducting 30 UTR luciferase as-
says, and performing biochemical assays
such as HITS-Clip, it appears that individ-
ual miRNAs might have many targets in a
given immune cell type. This complexity,
along with the relatively small amount by
which miRNAs repress their targets, has
challenged our capacity to firmly grasp
which targets are truly important in spe-
cific circumstances.
However, although the methods used
to identify miRNA targets have indicated
that individual miRNAs can target a wide
range of genes, they do not directly test
whether a given target gene is functionally
relevant. In fact, other experimental evi-
dence has indicated that the opposite
might be true. Some reports have shown
that certain miRNA-dependent pheno-
types can be largely, or at least partially,
explained by single target genes. Such
conclusions are based upon showing
that reducing the levels of specific miRNA
targets that become de-repressed in
miRNA knockout cells can partially or
completely rescue the miRNA phenotype.
This is achieved by using shRNAs (Simp-
son et al., 2014) or by crossing miRNA-
deficient mice to mice heterozygous for
a given target gene (Escobar et al., 2014)
to partially reduce the miRNA target in
question. Although these approaches
have yielded strong evidence that individ-
ual as opposed to large sets ofmiRNA tar-
gets are responsible for immunological
phenotypes, they have certain caveats
that must be taken into consideration.
For instance, removal of one allele of a
gene could impact expression of that
gene in cells where the miRNA underImmustudy is not expressed or during a cellular
developmental stage where the miRNA
has not yet been produced. This haploin-
sufficiency could trigger a miRNA-inde-
pendent phenotype that confounds the
study of the miRNA in question.
Although much has been learned from
the approaches mentioned above, the
gold standard for studying the relevance
of individual miRNA target genes during
cognate miRNA-dependent functions is
the genetic disruption of the miRNA bind-
ing site in the 30 UTR of an individual puta-
tive target gene. Such an approach can
be used to directly assess the importance
of a miRNA interacting with a specific
target gene during a cellular process.
In the current study, Lu et al. (2015)
clearly demonstrate that mice with a
mutant SOCS1 30 UTR that is unrespon-
sive to miR-155 are able to phenocopy
several, but not all, T and NK cell pheno-
types that are observed when mice lack
miR-155 (Figure 1). This interaction be-
tween miR-155 and SOCS1 plays an
important role in promoting T regulatory
(Treg) cell fitness in competitive reconsti-
tution assays. Additionally, this connec-
tion is essential for the survival and func-
tion of CD8+ T cells during chronic viral
infection with mouse LCMV clone 13.
Finally, miR-155-mediated repression of
SOCS1 is necessary for the expansion of
virus-specific natural killer (NK) cells in
response to MCMV infection. Taken
together, these results find that a single
miRNA-mRNA interaction is required for
a range of immunological functions by
multiple immune cell types.
Such an elegant approach has been re-
ported in the literature only a few times to
date, including the disruption of the miR-
155 target site in AID (Dorsett et al., 2008;
Teng et al., 2008) and PU.1 (Lu et al.,nity 43, July 21, 2015 ª2015 Elsevier Inc. 3
Figure 1. A Subset ofmiR-155 Functions in the Immune SystemRequire Direct Repression of
SOCS1
Repression of SOCS1 bymiR-155 is necessary for NK cell expansion in response toMCMV, for CD8+ T cell
expansion during chronic LCMV infection, and for Treg cell competitive fitness. However, miR-155 targets
other than SOCS1 are necessary for additional miR-155 functions, including promotion of cytokine pro-
duction by DCs, CD8+ T cell responses to acute viral infection, and Th17 cell differentiation.
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Previews2014). These mutant mouse strains were
used to show that these miR-155 targets
regulate B cell phenotypes. In the case
of disrupting miR-155 targeting of AID,
this led to a high degree of Myc-Igh trans-
locations and consequences for class-
switch recombination (CSR) and affinity
maturation of antibody genes. Alterna-
tively, preventing miR-155 inhibition of
PU.1 resulted in impaired T-cell-depen-
dent B cell responses. Taken together,
this approach has provided unequivocal
evidence that each of these targets, AID,
PU.1, and now SOCS1, is required for
certain aspects of miR-155 biology in the
immune system. However, it must be
kept in mind that just because a single
target is required for a phenotype does
not imply that additional targets are not
also involved. Thus, although prevention
of SOCS1 targeting by miR-155 does
hinder the above-mentioned phenotypes,4 Immunity 43, July 21, 2015 ª2015 Elsevierit is formally possible that one or many
additional targets also play obligatory
roles.
Although these studies have been truly
insightful, this approach to studying
miRNA targets has not been used very
often. Clearly this is a high-risk endeavor
because of the significant costs, in terms
of both financial and time investments,
and the potential for a putative target to
not be functionally relevant. With the
recent explosion of the genome-editing
field, as a result of the emergence of
Crispr-Cas9 technology, perhaps more
innovative, high-throughput approaches
to disrupting 30 UTR miRNA binding sites
can be developed and used to rapidly
screen for functionally important miRNA
targets in the context of specific immuno-
logical phenotypes.
In addition to clearly demonstrating
the requirement for miR-155 targeting ofInc.SOCS1 during some miR-155-dependent
immune responses, the current study also
points to the existence of additional miR-
155 targets that regulate SOCS1-inde-
pendent miR-155 phenotypes. These
include CD8+ T cell responses to acute
viral infection, DC production of inflam-
matory cytokines, and CD4+ T cell differ-
entiation into Th17 cells (Figure 1). Such
an understanding of how miRNAs selec-
tively use different targets to mediate
distinct functional effects is critical both
for our basic understanding of miRNA
biology and for our future capacity to
manipulate immune responses in the
clinic where it would be advantageous to
selectively inhibit or promote specific im-
mune responses without interfering with
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